¡Hola! Iniciá sesión
Inicio > Productos

Study Guide for Pharmacology

$75.582,00
10% de descuento pagando con Transferencia
Ver más detalles

FORMATO

Edicion

PAPEL

Edicion

EBOOK
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

Reinforce your understanding of nursing pharmacology and patient-centered care! Corresponding to the chapters in McCuistion’s Pharmacology, 11th Edition, this study guide provides hundreds of practice problems and questions to help you review and remember pharmacology concepts. It includes drug calculation problems along with review questions and case studies using the nursing process. To prepare you for the new Next Generation NCLEX® (NGN) examination, this edition adds NGN exam-style case studies. With this study guide, you will apply your knowledge of pharmacology to clinical practice, enhance your decision-making abilities, and develop clinical reasoning and critical thinking skills.

  • NCLEX® review questions in each chapter include application-level questions and Next Generation NCLEX examination-style questions, along with at least one alternate item question.
  • Detailed case studies enhance student understanding of nursing responsibilities in therapeutic pharmacology.
  • A Drug Calculations chapter provides students the opportunity to review their knowledge and practice their skills in drug dosage calculation.
  • Sample drug labels reflect the updated drug labels in McCuistion’s Pharmacology, 11th Edition textbook.
  • Focus on safety includes a special icon that calls attention to questions related to safe patient care.
  • Answers for all exercises are provided at the back of the book to make studying easier and include rationales for all application-level questions and case study questions.
  • NEW! Six cognitive skills of the Clinical Judgment Model are integrated into the practice questions and case studies.
  • NEW! Next Generation NCLEX® (NGN) examination-style case studies are included in most chapters, and the remaining chapters include classic critical thinking case studies.
  • NEW! Updated drug content matches the updates in McCuistion’s Pharmacology, 11th Edition textbook.

1. Section I: Introduction to Pharmacology - p. v 2. 1: Clinical Judgment Management Model (CJMM) and the Nursing Process - p. v 3. 2: Drug Development and Ethical Considerations - p. 3 4. 3: Pharmacokinetics and Pharmacodynamics - p. 6 5. 4: Pharmacogenetics - p. 9 6. 5: Complementary and Alternative Therapies - p. 11 7. 6: Pediatric Considerations - p. 14 8. 7: Drug Therapy in Older Adults - p. 16 9. 8: Drugs in Substance Use Disorder - p. 19 10. Section II: Pharmacotherapy and Drug Administration - p. 22 11. 9: Safety and Quality - p. 22 12. 10: Drug Administration - p. 25 13. 11: Drug Calculations - p. 28 14. Section III: Maintenance of Homeostasis - p. 68 15. 12: Fluid Volume and Electrolytes - p. 68 16. 13: Vitamin and Mineral Replacement - p. 71 17. 14: Nutritional Support - p. 76 18. Section IV: Autonomic Nervous System Drugs - p. 79 19. 15: Adrenergic Agonists and Antagonists - p. 79 20. 16: Cholinergic Agonists and Antagonists - p. 85 21. Section V: Central and Peripheral Nervous System Drugs - p. 89 22. 17: Stimulants - p. 89 23. 18: Depressants - p. 92 24. 19: Antiseizure Drugs - p. 94 25. 20: Drugs for Parkinsonism and Alzheimer Disease - p. 99 26. 21: Drugs for Neuromuscular Disorders and Muscle Spasms - p. 104 27. Section VI: Mental and Behavioral Health Drugs - p. 106 28. 22: Antipsychotics and Anxiolytics - p. 106 29. 23: Antidepressants and Mood Stabilizers - p. 109 30. Section VII: Pain and Inflammation Management Drugs - p. 113 31. 24: Antiinflammatories - p. 113 32. 25: Analgesics - p. 117 33. Section VIII: Antimicrobial Drugs - p. 122 34. 26: Penicillins, Other Beta-lactams, and Cephalosporins - p. 122 35. 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides - p. 124 36. 28: Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones - p. 126 37. 29: Sulfonamides and Nitroimidazoles Antibiotics - p. 129 38. 30: Antituberculars, Antifungals, and Antivirals - p. 132 39. 31: Antimalarials, Anthelmintics, and Peptides - p. 136 40. Section IX: Immunologic Drugs - p. 138 41. 32: HIV- and AIDS-Related Drugs - p. 138 42. 33: Transplant Drugs - p. 141 43. 34: Vaccines - p. 144 44. Section X: Antineoplastics and Biologic Response Modifiers - p. 147 45. 35: Anticancer Drugs - p. 147 46. 36: Targeted Therapies to Treat Cancer - p. 151 47. 37: Biologic Response Modifiers - p. 154 48. Section XI: Respiratory Drugs - p. 156 49. 38: Upper Respiratory Disorders - p. 156 50. 39: Lower Respiratory Disorders - p. 158 51. Section XII: Cardiovascular Drugs - p. 161 52. 40: Cardiac Glycosides, Antianginals, and Antidysrhythmics - p. 161 53. 41: Diuretics - p. 166 54. 42: Antihypertensives - p. 169 55. 43: Anticoagulants, Antiplatelets, and Thrombolytics - p. 175 56. 44: Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow - p. 179 57. Section XIII: Gastrointestinal Drugs - p. 182 58. 45: Gastrointestinal Tract Disorders - p. 182 59. 46: Antiulcer Drugs - p. 185 60. Section XIV: Eye, Ear, and Skin Drugs - p. 188 61. 47: Eye and Ear Disorders - p. 188 62. 48: Dermatologic Disorders - p. 191 63. Section XV: Endocrine Drugs - p. 194 64. 49: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders - p. 194 65. 50: Antidiabetics - p. 197 66. Section XVI: Renal and Urologic Drugs - p. 202 67. 51: Urinary Disorders - p. 202 68. Section XVII: Reproductive and Gender-Related Drugs - p. 205 69. 52: Pregnancy and Preterm Labor - p. 205 70. 53: Labor, Delivery, and Postpartum - p. 209 71. 54: Neonatal and Newborn - p. 213 72. 55: Women’s Reproductive Health - p. 216 73. 56: Men’s Reproductive Health - p. 218 74. 57: Sexually Transmitted Infections - p. 220 75. Section XVIII: Emergency Drugs - p. 222 76. 58: Adult and Pediatric Emergency Drugs - p. 222 77. Answer Key - p. 226 78. IBC - p. 306

Descripcion
Descripción

Reinforce your understanding of nursing pharmacology and patient-centered care! Corresponding to the chapters in McCuistion’s Pharmacology, 11th Edition, this study guide provides hundreds of practice problems and questions to help you review and remember pharmacology concepts. It includes drug calculation problems along with review questions and case studies using the nursing process. To prepare you for the new Next Generation NCLEX® (NGN) examination, this edition adds NGN exam-style case studies. With this study guide, you will apply your knowledge of pharmacology to clinical practice, enhance your decision-making abilities, and develop clinical reasoning and critical thinking skills.

  • NCLEX® review questions in each chapter include application-level questions and Next Generation NCLEX examination-style questions, along with at least one alternate item question.
  • Detailed case studies enhance student understanding of nursing responsibilities in therapeutic pharmacology.
  • A Drug Calculations chapter provides students the opportunity to review their knowledge and practice their skills in drug dosage calculation.
  • Sample drug labels reflect the updated drug labels in McCuistion’s Pharmacology, 11th Edition textbook.
  • Focus on safety includes a special icon that calls attention to questions related to safe patient care.
  • Answers for all exercises are provided at the back of the book to make studying easier and include rationales for all application-level questions and case study questions.
  • NEW! Six cognitive skills of the Clinical Judgment Model are integrated into the practice questions and case studies.
  • NEW! Next Generation NCLEX® (NGN) examination-style case studies are included in most chapters, and the remaining chapters include classic critical thinking case studies.
  • NEW! Updated drug content matches the updates in McCuistion’s Pharmacology, 11th Edition textbook.

1. Section I: Introduction to Pharmacology - p. v 2. 1: Clinical Judgment Management Model (CJMM) and the Nursing Process - p. v 3. 2: Drug Development and Ethical Considerations - p. 3 4. 3: Pharmacokinetics and Pharmacodynamics - p. 6 5. 4: Pharmacogenetics - p. 9 6. 5: Complementary and Alternative Therapies - p. 11 7. 6: Pediatric Considerations - p. 14 8. 7: Drug Therapy in Older Adults - p. 16 9. 8: Drugs in Substance Use Disorder - p. 19 10. Section II: Pharmacotherapy and Drug Administration - p. 22 11. 9: Safety and Quality - p. 22 12. 10: Drug Administration - p. 25 13. 11: Drug Calculations - p. 28 14. Section III: Maintenance of Homeostasis - p. 68 15. 12: Fluid Volume and Electrolytes - p. 68 16. 13: Vitamin and Mineral Replacement - p. 71 17. 14: Nutritional Support - p. 76 18. Section IV: Autonomic Nervous System Drugs - p. 79 19. 15: Adrenergic Agonists and Antagonists - p. 79 20. 16: Cholinergic Agonists and Antagonists - p. 85 21. Section V: Central and Peripheral Nervous System Drugs - p. 89 22. 17: Stimulants - p. 89 23. 18: Depressants - p. 92 24. 19: Antiseizure Drugs - p. 94 25. 20: Drugs for Parkinsonism and Alzheimer Disease - p. 99 26. 21: Drugs for Neuromuscular Disorders and Muscle Spasms - p. 104 27. Section VI: Mental and Behavioral Health Drugs - p. 106 28. 22: Antipsychotics and Anxiolytics - p. 106 29. 23: Antidepressants and Mood Stabilizers - p. 109 30. Section VII: Pain and Inflammation Management Drugs - p. 113 31. 24: Antiinflammatories - p. 113 32. 25: Analgesics - p. 117 33. Section VIII: Antimicrobial Drugs - p. 122 34. 26: Penicillins, Other Beta-lactams, and Cephalosporins - p. 122 35. 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides - p. 124 36. 28: Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones - p. 126 37. 29: Sulfonamides and Nitroimidazoles Antibiotics - p. 129 38. 30: Antituberculars, Antifungals, and Antivirals - p. 132 39. 31: Antimalarials, Anthelmintics, and Peptides - p. 136 40. Section IX: Immunologic Drugs - p. 138 41. 32: HIV- and AIDS-Related Drugs - p. 138 42. 33: Transplant Drugs - p. 141 43. 34: Vaccines - p. 144 44. Section X: Antineoplastics and Biologic Response Modifiers - p. 147 45. 35: Anticancer Drugs - p. 147 46. 36: Targeted Therapies to Treat Cancer - p. 151 47. 37: Biologic Response Modifiers - p. 154 48. Section XI: Respiratory Drugs - p. 156 49. 38: Upper Respiratory Disorders - p. 156 50. 39: Lower Respiratory Disorders - p. 158 51. Section XII: Cardiovascular Drugs - p. 161 52. 40: Cardiac Glycosides, Antianginals, and Antidysrhythmics - p. 161 53. 41: Diuretics - p. 166 54. 42: Antihypertensives - p. 169 55. 43: Anticoagulants, Antiplatelets, and Thrombolytics - p. 175 56. 44: Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow - p. 179 57. Section XIII: Gastrointestinal Drugs - p. 182 58. 45: Gastrointestinal Tract Disorders - p. 182 59. 46: Antiulcer Drugs - p. 185 60. Section XIV: Eye, Ear, and Skin Drugs - p. 188 61. 47: Eye and Ear Disorders - p. 188 62. 48: Dermatologic Disorders - p. 191 63. Section XV: Endocrine Drugs - p. 194 64. 49: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders - p. 194 65. 50: Antidiabetics - p. 197 66. Section XVI: Renal and Urologic Drugs - p. 202 67. 51: Urinary Disorders - p. 202 68. Section XVII: Reproductive and Gender-Related Drugs - p. 205 69. 52: Pregnancy and Preterm Labor - p. 205 70. 53: Labor, Delivery, and Postpartum - p. 209 71. 54: Neonatal and Newborn - p. 213 72. 55: Women’s Reproductive Health - p. 216 73. 56: Men’s Reproductive Health - p. 218 74. 57: Sexually Transmitted Infections - p. 220 75. Section XVIII: Emergency Drugs - p. 222 76. 58: Adult and Pediatric Emergency Drugs - p. 222 77. Answer Key - p. 226 78. IBC - p. 306

Indice
Autores
Muestra
Ficha Técnica